INFANT is answering the international need for research and innovation to improve healthcare outcomes for mothers and children.

Ireland, with the highest birth rate in the EU, is an ideal place to consolidate international experts, enabling our researchers to make a marked impact.

Achievements

Scientific Breakthroughs

AI powered neonatal seizure detection

This system automatically analyses and identifies seizures in newborn babies using EEG readings of the brain. Using artificial intelligence that detects brain seizures in newborns, INFANT has developed a new medical device for seizure detection in neonates that sets off an alarm at the cotside when baby seizures occur.

Predictive screening tests for pre-eclampsia

Affecting 5% of first-time mothers, preeclampsia is one of the most common complications of pregnancy and is a leading cause of maternal and infant illness and death. Using the latest technology to study metabolites, INFANT researchers discovered a set of biomarkers, which identify women at risk of developing the disease.

New therapy for peanut allergy

Clinical trials co-led by an INFANT principal investigator and supported by the Clinical Research Facility in Cork, have found that a new oral treatment, can successfully reduce sensitivity to peanuts, offering a real lifeline to those affected by the most common food allergy and the single cause of most food allergy deaths.

Our Global Impact

Success Stories

We put our stamp on Ireland

INFANT Research Honoured With Collector’s Stamp from An Post.

Learn More…

Breakthrough for brain injury

INFANT research identifies biomarkers to detect brain injury.

Learn More…

A caring service
for those that lose a baby

INFANT leads National Bereavement Standards in Maternity Services.

Learn More…

Contact Us

Do you want to find out more about INFANT? If so, you can contact us via the Email address or Phone number below:

Email: infant@ucc.ie

Phone: 021 420 5082